Seasonal Pick Nkx-3.1 Rabbit Pab Save 55% Now [t4bk5DOz]

Nkx-3.1 Rabbit Polyclonal Antibody

Introducing the Nkx-3.1 Rabbit Polyclonal Antibody, a premium research tool designed for accurate and reliable detection of Nkx-3.1 protein in various experimental settings. This antibody offers exceptional specificity and sensitivity, making it an ideal choice for researchers seeking high-quality results. With its robust performance, the Seasonal Pick Nkx-3.1 Rabbit Pab Save 55% Now [t4bk5DOz] is suitable for a wide range of applications, including immunohistochemistry, immunofluorescence, and Western blotting.

• High Specificity: Ensures accurate detection of Nkx-3.1 protein without cross-reactivity.
• Superior Sensitivity: Allows for detection of low protein concentrations, providing greater flexibility in experimental design.

The Nkx-3.1 Rabbit Polyclonal Antibody is produced using rabbit immunoglobulins, which offer a robust immune response. This antibody is affinity-purified to remove unwanted proteins, ensuring purity and reducing the risk of false-positive results. The antibody recognizes the Nkx-3.1 protein at an amino acid sequence of 596-614, providing a reliable target for your research. The product is supplied in a liquid format, making it easy to use and store.

• Quality Control: Affinity-purified for purity and specificity.
• Concentration: 1mg/ml in PBS, pH 7.4, containing 0.02% sodium azide.

The Nkx-3.1 Rabbit Polyclonal Antibody is an essential tool for researchers studying Nkx-3.1 expression in various biological processes, including development, differentiation, and disease. Whether you are investigating the role of Nkx-3.1 in cancer, neurodegenerative disorders, or developmental biology, this antibody can provide valuable insights. Its versatility makes it a valuable addition to any laboratory's toolkit, and its ease of use ensures efficient experimental workflows.

• Applications: Immunohistochemistry, immunofluorescence, Western blotting.
• Target Audience: Researchers in developmental biology, cancer research, and neurodegenerative disorders.